Research identifies the herbal supplements that are effective in treating anxiety

Oct 07, 2010

A systematic review of research into the use of nutritional supplements for the treatment of anxiety disorders has found strong evidence for the use of extracts of passionflower or kava and combinations of L-lysine and L-arginine. Researchers writing in BioMed Central's open access Nutrition Journal pooled the results of 24 studies involving a total of more than 2000 participants, showing that some nutritional and herbal supplements can be effective, without the risk of serious side effects.

The research was carried out by Shaheen Lakhan and Karen Vieira from the Global Neuroscience Initiative Foundation, a non-profit charity organization for the advancement of neurological and mental health patient welfare, education, and research, based in Los Angeles, USA. Lakhan said, "Our review and summary of the literature on herbal remedies and dietary supplements for should aid mental health practitioners in advising their patients and provide insight for future research in this field. We found mixed results - while passionflower or kava and L-lysine and L-arginine appeared to be effective, St John's Wort and magnesium supplements were not".

Of the studies included in the review, 21 were . Of these, 15 showed positive effects from either a nutritional or herbal remedy and any reported side effects were mild to moderate. According to Lakhan, "For all three of the herbal supplements we reviewed, more research needs to be done to establish the most effective dosage and to determine whether this varies between different types of anxiety or anxiety-related disorders. Herbal medicines hold an important place in the history of medicine as most of our current remedies, and the majority of those likely to be discovered in the future, will contain phytochemicals derived from plants".

Explore further: Acne pill benefits outweigh blood clot risk: EU agency

More information: Nutritional and herbal supplements for anxiety and anxiety-related disorders: systematic review, Shaheen E Lakhan and Karen F Vieira, Nutrition Journal (in press), www.nutritionj.com/

add to favorites email to friend print save as pdf

Related Stories

SLU doctor warns against St. John's wort for anxiety

Apr 06, 2010

In a broad-based review of studies focused on drugs that treat anxiety, a Saint Louis University doctor found no evidence supporting the use of so-called "natural" treatments in combating the effects of anxiety.

How safe and effective are herbal dietary supplements?

Jul 21, 2010

Millions of people are taking herbs and other plant-based dietary supplements to improve their health, but they have precious little information on the actual effectiveness or potential ill effects of these products. That's ...

Herbal medicines could treat gastrointestinal disease

Mar 25, 2009

Herbal medicines could benefit patients suffering from gastrointestinal (GI) motility disorders that cannot be treated using conventional drug therapy. In a study published in Neurogastroenterology and Motility, researchers review ...

St. John's wort relieves symptoms of major depression

Oct 08, 2008

New research provides support for the use of St. John's wort extracts in treating major depression. A Cochrane Systematic Review backs up previous research that showed the plant extract is effective in treating mild to moderate ...

Recommended for you

First influenza vaccine brought to clinical testing

May 17, 2013

Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their ...

Aspirin not always best treatment for many individuals

May 16, 2013

(Medical Xpress)—An aspirin a day may not always keep heart disease away, say two University of Florida cardiologists. But a new algorithm they have developed outlines factors physicians should weigh as ...

FDA: lower ambien's dose to prevent drowsy driving

May 15, 2013

(HealthDay)—The U.S. Food and Drug Administration has approved new, lower-dose labeling for the popular sleep drug Ambien (zolpidem) in an effort to cut down on daytime drowsiness that could be a hazard ...

Simponi approved for ulcerative colitis

May 15, 2013

(HealthDay)—Simponi (golimumab) injection has been approved by the U.S. Food and Drug Administration to treat adults with moderate-to-severe ulcerative colitis.

FDA approves genetic test for lung cancer drug

May 14, 2013

The Food and Drug Administration says it approved a genetic test from Roche to help doctors identify patients who can benefit from a lung cancer drug made by Genentech.

User comments : 0

More news stories

Heat-related deaths in Manhattan projected to rise

Residents of Manhattan will not just sweat harder from rising temperatures in the future, says a new study; many may die. Researchers say deaths linked to warming climate may rise some 20 percent by the 2020s, ...

Kinks and curves at the nanoscale

One of the basic principles of nanotechnology is that when you make things extremely small—one nanometer is about five atoms wide, 100,000 times smaller than the diameter of a human hair—they are going ...